Reassessing Gabapentinoids in Chronic Obstructive Pulmonary Disease: Emerging Respiratory Safety Concerns
Saved in:
| Main Author: | A. Alcántara Montero |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | COPD |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15412555.2025.2542157 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk of Severe Exacerbation Associated with Gabapentinoid Use in Patients with Chronic Obstructive Pulmonary Disease: A Population-Based Cohort Study
by: Omotayo Olaoye, et al.
Published: (2025-12-01) -
Chronic Obstructive Pulmonary Disease in the Emergency Department
by: Nick R Anthonisen
Published: (2008-01-01) -
Asthma-chronic obstructive pulmonary disease misdiagnosis: cause for concern or false alarm?
by: M S Barthwal, et al.
Published: (2025-06-01) -
Chronic infection: as an ecological model for emergence of the chronic obstructive pulmonary disease
by: Dmitriy V. Alekseev, et al.
Published: (2023-10-01) -
Functional State of Respiratory Muscles in Patients with Chronic Obstructive Pulmonary Disease
by: I. G. Kurpаtov, et al.
Published: (2021-07-01)